Pricing Log in Create free account

Kalaris Therapeutics Inc. (KLRS) vs Tevogen Inc. (TVGN)

Kalaris Therapeutics Inc. and Tevogen Inc. are both Biotechnology companies. Kalaris Therapeutics Inc. and Tevogen Inc. are of similar size ($47.8M and $46.1M). Across the 8 metrics below, Tevogen Inc. leads on 5 and Kalaris Therapeutics Inc. on 3.

Valuation

Metric KLRS TVGN Biotechnology median
P/E n/m n/m 8.50
P/S n/m n/m 9.71
P/B 0.83 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.55 n/m 0.64
EV/Sales n/m n/m 9.21
Earnings yield (101.00%) (87.71%) (33.15%)
Free cash flow yield (85.89%) (42.97%) (25.50%)

Profitability

Metric KLRS TVGN Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (79.91%) 123.10% (56.36%)
Return on assets (46.02%) (492.20%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric KLRS TVGN Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) 94.50% (72.66%) 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric KLRS TVGN Biotechnology median
Debt to equity 0.00 (0.72) 0.00
Current ratio 10.98 0.33 4.72
Net debt to EBITDA 2.54 (0.15) 0.96

Dividend

Metric KLRS TVGN Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric KLRS TVGN Biotechnology median
Market cap 47.83m 46.10m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack